Welcome to our dedicated page for McEwen SEC filings (Ticker: MUX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The McEwen Inc. (MUX) SEC filings page on Stock Titan provides direct access to the company’s U.S. regulatory disclosures, together with AI-assisted summaries to help interpret complex documents. As a Colorado corporation listed on the New York Stock Exchange, McEwen files current reports on Form 8-K and other periodic reports that describe material events affecting its gold, silver and copper business across the Americas.
In recent Form 8-K filings, McEwen has reported on a range of topics, including the business combination with Canadian Gold Corp. that added the Tartan Mine Project in Manitoba, the extension of the Environmental Impact Assessment for the El Gallo Mine in Mexico, and strategic investments such as the share exchange agreement to acquire an interest in Paragon Geochemical Laboratories. Other 8-Ks discuss financing transactions like flow-through share offerings, appointments of senior executives, and technical and feasibility milestones at the Los Azules copper project in San Juan, Argentina.
Through this page, users can review McEwen’s filings to see how the company describes its operations at the Gold Bar Mine Complex in Nevada, the Fox Complex in Ontario, the San José Mine in Argentina, the El Gallo Mine in Mexico and its 46.4% interest in McEwen Copper. AI-powered tools highlight key sections of lengthy filings, such as risk factor discussions, descriptions of material agreements, and summaries of technical and permitting developments.
Investors researching MUX can use the filings page to locate quarterly and annual reports when available (Forms 10-Q and 10-K), current reports on Form 8-K, and exhibits referenced in those filings. The inclusion of insider and financing-related disclosures, where filed, helps users understand equity issuances, ownership changes and other regulatory events that may influence the company’s capital structure and project funding.
Jeffrey Chan, Vice President - Finance at McEwen Inc. (MUX), reported transactions on 09/22/2025. The filing shows he acquired a stock option covering 13,333 shares with an exercise price of $7.10 and an exercisable schedule that vests in three equal annual installments beginning 06/29/2024, and that after the option his direct beneficial ownership of the option equals 13,333 underlying shares. On the same date he sold 13,333 common shares in multiple transactions at a weighted-average price of $14.8898 (individual sale prices ranged $14.59–$15.103). Following the reported trades his direct common stock holdings are shown as 2,267 shares and he holds options underlying 13,333 shares (6,667 shown exercisable now). The filing is a routine Section 16 disclosure of insider exercises and sales.
Carmen L. Diges, General Counsel and Corporate Secretary of McEwen Inc. (MUX), exercised 210,000 stock options at a $1.25 exercise price and simultaneously sold 21,000 shares at a weighted-average price of $14.3446 on 09/19/2025. The option exercise increased reported direct beneficial ownership to 236,096 shares before the sale and to 215,096 shares after the sale. The exercised options were part of a grant that vested in three equal annual installments beginning 09/29/2021 and were nearing their 09/28/2025 expiration.
Robert R. McEwen, Chairman and CEO of McEwen Inc. (MUX), exercised stock options and reported related open-market sales. He exercised an option to acquire 500,000 common shares at an exercise price of $1.25 per share, and immediately sold 50,000 shares at a weighted-average price of $14.3467. After these transactions, Mr. McEwen directly beneficially owned 500,000 shares; an additional 8,236,647 shares are held indirectly by a corporation wholly owned by him (2190303 Ontario Inc.), and 35,280 shares are held indirectly by his spouse. The filing notes the option vested in three equal annual installments beginning September 29, 2021, and that the option was nearing its September 28 expiration.
Robert R. McEwen, Chairman and CEO of McEwen Inc. (MUX), amended a Form 4 to report acquisitions tied to a loan arrangement. On 05/06/2025, 2190303 Ontario Inc., a company wholly owned by Mr. McEwen, received 53,160 common shares as partial consideration for extending a loan to McEwen Copper Inc., an entity in which McEwen Inc. holds an indirect 46.6% equity interest. The shares were valued at $7.5245 each using the NYSE volume-weighted average price from 02/18/2025 to 03/31/2025. The filing also notes 35,280 shares held indirectly by spouse. The amendment clarifies the transaction is exempt from Section 16(b) under Rule 16b-3(d) and that the loan was made to the equity investee, not McEwen Inc.
McEwen Inc. appointed Ian Ball as Vice-Chairman effective September 3, 2025. In this new role, he will oversee and align all revenue-generating activities and lead shareholder engagement, giving him a central position in the company’s commercial strategy.
On September 10, 2025, the company and Mr. Ball executed an offer letter setting his annual salary at CAD$435,000, with eligibility to participate in employee benefit plans consistent with other senior executives. He will also receive an option to purchase 50,000 shares of McEwen’s common stock, with the exercise price set at the time of grant, and will be eligible for awards under the 2024 Equity and Incentive Plan.
Because he is moving into an executive role, Mr. Ball will no longer receive non-employee director compensation. He has stepped down from the Audit Committee, and Nicolas Darveau-Garneau has been appointed to that committee as his replacement.
McEwen Inc. (MUX) director Stephen Douglas Kaszas reported an acquisition of 726 deferred stock units on 09/08/2025. Each deferred stock unit represents the right to receive one share of McEwen common stock. The units are fully vested and will be delivered to Mr. Kaszas upon his termination of continuous service on the Board, unless he elects to defer delivery beyond that date. The Form 4 was signed on 09/10/2025 and was filed as an individual report by one reporting person. No exercise price applies because these are deferred stock units rather than options.
McEwen Inc. (MUX) director Dalia Nadine Asterbadi reported a grant of 726 deferred stock units on 09/08/2025. Each deferred stock unit represents the right to receive one share of the company's common stock. The units are fully vested and carry a $0 purchase price; they will be delivered to the reporting person upon termination of continuous service on the Board unless she elects to defer delivery beyond that date. The Form 4 was signed on 09/10/2025 and filed to disclose this change in beneficial ownership.
John Casimir Florek, a director of McEwen Inc. (MUX), received 726 deferred stock units on 09/08/2025 that each convert to one share of common stock. The deferred stock units are fully vested and were reported as acquired at a $0 price; they will be delivered to Mr. Florek on the date his continuous service on the board ends, unless he elects to defer delivery beyond that date. Following the reported transaction, the filing shows 726 shares beneficially owned by Mr. Florek. The Form 4 is signed and dated 09/10/2025.
William M. Shaver, Chief Operating Officer and director of McEwen Inc. (MUX), was granted 2,600 restricted stock units (RSUs) on 09/08/2025. Each RSU represents a contingent right to one share of common stock or its cash value at the committee's discretion. The RSUs vest in three approximately equal installments on November 10, 2025, December 28, 2025 and June 28, 2026. Following the grant, Mr. Shaver beneficially owns 2,600 shares on a direct basis attributable to these units. The reported grant shows a $0 price per unit under the award terms. The Form 4 was signed by Mr. Shaver on 09/10/2025.
Perry Ing, Chief Financial Officer and director of McEwen Inc. (MUX), was granted 2,400 restricted stock units on 09/08/2025. Each unit represents a contingent right to receive one share of common stock or the cash value instead, at the issuer's discretion. The award carries no direct cash purchase price ($0) and is reported as 2,400 shares beneficially owned following the grant.
The restricted stock units vest in three equal installments on 11/10/2025, 12/28/2025 and 06/28/2026, and are held directly. The Form 4 was signed by Perry Ing on 09/10/2025 and discloses the grant terms without additional compensation or transaction details beyond the vesting schedule and unit count.
FAQ
What is the current stock price of McEwen (MUX)?
What is the market cap of McEwen (MUX)?
